Published in Aliment Pharmacol Ther on November 09, 2011
Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes. JAMA (2016) 1.52
Single nucleotide polymorphisms of caudal type homeobox 1 and 2 are associated with Barrett's esophagus. Dig Dis Sci (2013) 1.42
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol (2015) 1.17
LINX(®) Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux. Therap Adv Gastroenterol (2013) 0.95
Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation. Nat Rev Gastroenterol Hepatol (2011) 0.91
Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France. BMC Gastroenterol (2013) 0.85
The rapid rise in gastroesophageal junction tumors: is inflammation of the gastric cardia the underwater iceberg? Gastroenterology (2013) 0.84
EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc (2014) 0.84
Necrotizing sialometaplasia-like change of the esophageal submucosal glands is associated with Barrett's esophagus. Virchows Arch (2014) 0.80
Barrett's esophagus in 2016: From pathophysiology to treatment. World J Gastrointest Pharmacol Ther (2016) 0.76
Partial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA. Pragmat Obs Res (2012) 0.75
Online follow-up of individuals with gastroesophageal reflux disease using a patient-reported outcomes instrument: results of an observational study. BMC Gastroenterol (2013) 0.75
LINX(®), a novel treatment for patients with refractory asthma complicated by gastroesophageal reflux disease: a case report. J Med Case Rep (2016) 0.75
The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus. Drugs (2017) 0.75
Evolution of GERD over 5 years. Aliment Pharmacol Ther (2012) 0.75
Mucosal breaks show same circumferential distribution in majority of patients with recurrent reflux esophagitis. Endosc Int Open (2017) 0.75
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet (1997) 7.59
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet (1995) 6.32
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66
Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology (1997) 4.59
Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer (2000) 4.55
Acupuncture in patients with osteoarthritis of the knee: a randomised trial. Lancet (2005) 4.08
Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer (1998) 3.98
Circadian variation in the frequency of sudden cardiac death. Circulation (1987) 3.98
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut (2004) 3.80
Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man. Gut (1983) 3.46
Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst (1997) 3.30
Acupuncture in patients with headache. Cephalalgia (2008) 3.07
Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther (1997) 3.02
Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med (1987) 2.83
Non-alcoholic duct destructive chronic pancreatitis. Gut (1997) 2.79
Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology (1999) 2.72
Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg (1996) 2.69
Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology (2000) 2.66
Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24,061 consecutive cases. Eur Heart J (2000) 2.52
[Meta-analyses are hardly suitable for conclusively proving medical controversies]. Z Gastroenterol (1996) 2.47
A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut (1997) 2.32
The predictive value of specific immunoglobulin E levels in serum for the outcome of oral food challenges. Clin Exp Allergy (2005) 2.31
Bassoon, a novel zinc-finger CAG/glutamine-repeat protein selectively localized at the active zone of presynaptic nerve terminals. J Cell Biol (1998) 2.30
Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol (1987) 2.27
Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Gut (2008) 2.20
Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagus. Endoscopy (2010) 2.11
Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther (2009) 2.11
Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol (1989) 2.09
Gallstone ileus treated by extracorporeal shockwave lithotripsy. Gastrointest Endosc (1996) 2.08
Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother (1999) 2.07
Attempted endoscopic en bloc resection of mucosal and submucosal tumors using insulated-tip knives: a pilot series. Endoscopy (2004) 2.07
Establishment of a typing system for group D streptococci. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 2.07
PCR-positive tests for Tropheryma whippelii in patients without Whipple's disease. Lancet (1999) 2.05
Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol (2000) 2.03
Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology (1986) 2.02
Magnetic resonance imaging pelvimetry: a useful adjunct in the management of the obese patient. Br J Obstet Gynaecol (1992) 2.02
[Short guideline for the management of dyspepsia]. Dtsch Med Wochenschr (2004) 2.01
Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: proposal for a new classification system of gastrointestinal epithelial neoplasia. J Gastroenterol Hepatol (2000) 2.01
A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics (1999) 2.00
Changes in sputum composition between two inductions performed on consecutive days. Thorax (1998) 1.98
Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro-oesophageal reflux disease on oesophageal biopsy material. Histopathology (2008) 1.97
Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy (2007) 1.94
Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc (2000) 1.94
Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol (2001) 1.93
One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol (1995) 1.93
Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology (1998) 1.92
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91
Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol (1999) 1.90
In vivo diagnosis of collagenous colitis by confocal endomicroscopy. Gut (2006) 1.82
Pyloric gland adenoma: a clinico-pathological analysis of 90 cases. Virchows Arch (2003) 1.82
Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch (1998) 1.79
["A sick public health services watches over health status": how the former Federal Public Health Office turned German medicine exemplified by "omeprazole and blindness" into an international joke]. Leber Magen Darm (1994) 1.78
Obesity, inflammation, and periodontal disease. J Dent Res (2007) 1.77
Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology (2000) 1.76
Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology (1997) 1.75
Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy. J Clin Pathol (2006) 1.75
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2. Mech Dev (1998) 1.74
Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol (1999) 1.74
Prevalence of intestinal metaplasia in Helicobacter pylori gastritis. Scand J Gastroenterol (1994) 1.73
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology (1992) 1.70
Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology (1996) 1.67
Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience. Gut (1998) 1.67
Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans. Gastroenterology (1982) 1.66
ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology (1999) 1.66
Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor alpha as a new therapeutic option. Ann Rheum Dis (2004) 1.65
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64
Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. Am Heart J (1989) 1.62
A special form of segmental pancreatitis: "groove pancreatitis". Hepatogastroenterology (1982) 1.62
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant (2008) 1.61
Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia (2004) 1.59
Animal reservoirs in the transmission of Helicobacter heilmannii. Results of a questionnaire-based study. Scand J Gastroenterol (1998) 1.58
Histological analysis of endoscopic resection specimens from 326 patients with Barrett's esophagus and early neoplasia. Endoscopy (2004) 1.58
Health-related quality of life in patients with pancreatic cancer. Digestion (2006) 1.57
Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis (2006) 1.57